Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of Neurofilament Light Chain (NfL) Levels in Newborns Diagnosed With Hypoxic Ischemic Encephalopathy: A Case-Control Study

NCT07292220 is registered in ClinicalTrials.gov with Mustafa Gürkan as lead sponsor.

NCT NCT07292220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07292220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of Neurofilament Light Chain (NfL) Levels in Newborns Diagnosed With Hypoxic Ischemic Encephalopathy: A Case-Control Study
Lead sponsor
Mustafa Gürkan
Phase
Observational
Overall status
Not yet recruiting
Start date
December 15, 2025
Completion date
August 1, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypoxic-ischemic encephalopathy